Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal magnesium sulfate added to Marcaine for post-cesarean pain control
IRCT20190123042473N1Phase 3Completed
- Sponsor
- Vice Chancellor for Research, Birjand University of Medical Sciences
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of magnesium sulfate and bupivacaine in postoperative pain (2 arms), sponsored by Vice Chancellor for Research, Birjand University of Medical Sciences. Primary endpoints: Pain, Blood pressure and 1 more. Started Feb 2018; status: completed.
02
Drugs
magnesium sulfatebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20190123042473N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190123042473N1.